2024医药制造行业人才趋势报告

Industry Overview - The pharmaceutical manufacturing industry in China achieved a revenue of 2520.57 billion yuan in 2023, a year-on-year decrease of 3.7%, with a profit of 347.3 billion yuan, down by 15.1% [4] - The industry is facing challenges such as intensified market competition and product homogenization, with many small-scale enterprises relying on generic drugs for survival [4] - The industry's export delivery value in 2023 was 201.29 billion yuan, a 22.8% decrease compared to 2022 [4] Policy and Innovation - The "14th Five-Year Plan" for the pharmaceutical industry emphasizes strengthening quality management throughout the lifecycle of drugs and medical devices, and increasing the number of generic drugs passing consistency evaluations [6] - The "Traditional Chinese Medicine Revitalization and Development Major Project Implementation Plan" aims to promote the high-quality development of the TCM industry [6] - The "Deepening Medical and Health System Reform 2024 Key Tasks" focuses on centralized procurement of drugs and medical consumables, and promoting the high-quality development of public hospitals [6] Investment and Financing - In 2023, there were 238 financing cases in the domestic pharmaceutical manufacturing sector, with a total financing amount of 26.149 billion yuan, a year-on-year decrease of 22.48% and 41.08% respectively [8] - Key financing events in Q1 2024 include Zhiyi Biology's nearly 100 million yuan Series C financing and Huatai's 600 million yuan Series B financing [9] Technological Advancements - AI is playing an increasingly important role in pharmaceutical manufacturing, improving production efficiency, reducing R&D costs, and optimizing supply chain management [11] - In 2023, the number of new drug registration applications in China increased significantly, with TCM registration applications rising by 131.05% year-on-year [11] Talent Market - The pharmaceutical manufacturing industry is experiencing a talent shortage, with the Talent Shortage Index (TSI) consistently higher than the industry average [14] - Shanghai, Beijing, Guangzhou, and Chengdu are the most active cities for pharmaceutical manufacturing talent, with Shanghai's active talent pool increasing by 16.48% year-on-year [16] - The average annual salary in the pharmaceutical manufacturing industry has been rising, with Shanghai leading at 295,000 yuan [18] Recruitment Trends - The demand for high-quality R&D talent is increasing, particularly in fields such as biopharmaceuticals and genetic engineering [30] - Enterprises with 100-499 employees have the highest demand for talent, accounting for 23.90% of total demand [32] - The average recruitment salary in the industry is on the rise, with 15-20% of positions offering salaries between 150,000 and 200,000 yuan [34] Digital Transformation - Digital technologies such as AI are being used to optimize recruitment processes, improve efficiency, and reduce costs [39] - AI-powered tools like Doris, the digital interviewer, are being used to enhance the accuracy and fairness of candidate assessments [39] Employer Branding - Building a strong employer brand is crucial for attracting and retaining talent, with social media and online platforms playing a key role in showcasing company culture and values [41] - Encouraging employees to share their work experiences on social media can enhance the company's attractiveness and credibility [41]